Automated Author ProfileSilva, Anaclécia Ferreira da
Silva, Anaclécia Ferreira da
Current S-Index
Sum of Dataset Indices for all datasets
Average Dataset Index per Dataset
Average Dataset Index per dataset
Total Datasets
Total datasets for this author
Average FAIR Score
Average FAIR Score per dataset
Total Citations
Total citations to the author's datasets
Total Mentions
Total mentions of the author's datasets
S-Index Interpretation
The S-Index (Sharing Index) is a comprehensive metric that represents the cumulative impact of all your datasets. It is calculated as the sum of Dataset Index scores across all your claimed datasets.
What it means:
- A higher S-index indicates greater overall impact of your datasets relative to typical datasets in their fields of research
- The S-Index grows as you add more datasets or as existing datasets gain more citations and mentions
- It provides a single number to track your research data impact over time
Current S-Index: 0.6 (sum of 2 datasets Dataset Index scores)
More information here.
S-Index Over Time
Cumulative Citations Over Time
Cumulative Mentions Over Time
Datasets
ABSTRACT Objective: to identify and map health care aimed at onco-hematological patients in times of Coronavirus 2019. Methods: this is a scoping review, anchored in the Joanna Briggs Institute theoretical framework, registered in the Open Science Framework, with searches carried out in June 2021, through searches in the databases. Results: a final sample consisting of 20 articles was obtained, with emphasis on general care, treatment and stem cell donation. The most reported care was the use of telemedicine, screening for Coronavirus Disease 2019, compliance with prevention practices and, in case of infection, postponing procedures. Conclusions: the study gathered the main evidence on care aimed at treating these patients in times of a pandemic. Such measures help in the clinical management with the objective of proceeding with treatment amidst the injuries caused, thus minimizing possible complications.
Authors
- Nascimento, Anália Andréia de Araújo ;
- Torres, Débora Valéria de Oliveira ;
- Silva, Anderson Felipe Moura da ;
- Rocha, Mayane Cleisla dos Santos ;
- Silva, Anaclécia Ferreira da ;
- Azevedo, Isabelle Campos de
ABSTRACT Objective: to identify and map health care aimed at onco-hematological patients in times of Coronavirus 2019. Methods: this is a scoping review, anchored in the Joanna Briggs Institute theoretical framework, registered in the Open Science Framework, with searches carried out in June 2021, through searches in the databases. Results: a final sample consisting of 20 articles was obtained, with emphasis on general care, treatment and stem cell donation. The most reported care was the use of telemedicine, screening for Coronavirus Disease 2019, compliance with prevention practices and, in case of infection, postponing procedures. Conclusions: the study gathered the main evidence on care aimed at treating these patients in times of a pandemic. Such measures help in the clinical management with the objective of proceeding with treatment amidst the injuries caused, thus minimizing possible complications.
Authors
- Nascimento, Anália Andréia de Araújo ;
- Torres, Débora Valéria de Oliveira ;
- Silva, Anderson Felipe Moura da ;
- Rocha, Mayane Cleisla dos Santos ;
- Silva, Anaclécia Ferreira da ;
- Azevedo, Isabelle Campos de